DE2725713A1 - Neue derivate von 3-alkyl-1,9-dihydroxy- und -1-hydroxy-9-keto-dibenzo eckige klammer auf b,d eckige klammer zu pyranen - Google Patents

Neue derivate von 3-alkyl-1,9-dihydroxy- und -1-hydroxy-9-keto-dibenzo eckige klammer auf b,d eckige klammer zu pyranen

Info

Publication number
DE2725713A1
DE2725713A1 DE19772725713 DE2725713A DE2725713A1 DE 2725713 A1 DE2725713 A1 DE 2725713A1 DE 19772725713 DE19772725713 DE 19772725713 DE 2725713 A DE2725713 A DE 2725713A DE 2725713 A1 DE2725713 A1 DE 2725713A1
Authority
DE
Germany
Prior art keywords
dibenzo
pyran
hexahydro
trans
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772725713
Other languages
German (de)
English (en)
Inventor
Bernard John Abbott
Robert Allen Archer
David Shuichi Fukuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE2725713A1 publication Critical patent/DE2725713A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/832—Bacillus
    • Y10S435/834—Bacillus cereus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/931—Mucor

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
DE19772725713 1976-06-09 1977-06-07 Neue derivate von 3-alkyl-1,9-dihydroxy- und -1-hydroxy-9-keto-dibenzo eckige klammer auf b,d eckige klammer zu pyranen Withdrawn DE2725713A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/694,512 US4064009A (en) 1976-06-09 1976-06-09 Novel 3-(oxygenated alkyl)-1,9-dihydroxy and 1-hydroxy-9-keto dibenzo[b,d]py

Publications (1)

Publication Number Publication Date
DE2725713A1 true DE2725713A1 (de) 1977-12-22

Family

ID=24789127

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772725713 Withdrawn DE2725713A1 (de) 1976-06-09 1977-06-07 Neue derivate von 3-alkyl-1,9-dihydroxy- und -1-hydroxy-9-keto-dibenzo eckige klammer auf b,d eckige klammer zu pyranen

Country Status (28)

Country Link
US (2) US4064009A (enExample)
JP (1) JPS52151173A (enExample)
AR (1) AR214636A1 (enExample)
AT (1) AT356049B (enExample)
AU (1) AU508677B2 (enExample)
BE (1) BE855347A (enExample)
BG (1) BG30773A3 (enExample)
CA (1) CA1097237A (enExample)
CH (1) CH640000A5 (enExample)
CS (1) CS189599B2 (enExample)
DD (1) DD131020A5 (enExample)
DE (1) DE2725713A1 (enExample)
DK (1) DK144971C (enExample)
ES (1) ES459644A1 (enExample)
FR (1) FR2354326A1 (enExample)
GB (1) GB1583062A (enExample)
GR (1) GR66428B (enExample)
HU (1) HU174139B (enExample)
IE (1) IE44992B1 (enExample)
IL (1) IL52248A (enExample)
NL (1) NL7706276A (enExample)
NZ (1) NZ184332A (enExample)
PH (1) PH12513A (enExample)
PL (1) PL106942B1 (enExample)
PT (1) PT66627B (enExample)
RO (1) RO73175A (enExample)
SE (1) SE413779B (enExample)
ZA (1) ZA773467B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948732A (en) * 1989-02-10 1990-08-14 Schering Corporation Microbiological chiral reduction of carbonyl groups
DE4034218A1 (de) * 1990-10-27 1992-04-30 Merck Patent Gmbh Verfahren zur herstellung von carebastin
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
CN1377261A (zh) 1999-03-22 2002-10-30 免疫力药品有限公司 治疗免疫疾病
US20020137802A1 (en) * 2000-09-28 2002-09-26 Travis Craig R. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
WO2002026728A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
WO2003080043A1 (en) * 2002-03-18 2003-10-02 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822188A (en) * 1972-10-19 1974-07-02 Abbott Lab Method of producing 1,4'-dihydroxy-3-n-pentyl-6,6,9-trimethyl-6a,7,10,10a-tetra-hydrodibenzo(b,d)pyran
DE2335136A1 (de) * 1973-07-06 1975-01-16 Schering Ag 7-hydroxy-delta hoch 8-tetrahydrocannabinole

Also Published As

Publication number Publication date
SE7706692L (sv) 1977-12-10
NZ184332A (en) 1978-09-20
AU508677B2 (en) 1980-03-27
IE44992B1 (en) 1982-06-02
CA1097237A (en) 1981-03-10
SE413779B (sv) 1980-06-23
PL198731A1 (pl) 1978-04-10
JPS52151173A (en) 1977-12-15
BE855347A (fr) 1977-12-05
IL52248A0 (en) 1977-08-31
ES459644A1 (es) 1978-04-01
PT66627B (en) 1978-11-09
PL106942B1 (pl) 1980-01-31
RO73175A (ro) 1981-11-24
CS189599B2 (en) 1979-04-30
NL7706276A (nl) 1977-12-13
AU2593577A (en) 1978-12-14
FR2354326A1 (fr) 1978-01-06
ZA773467B (en) 1979-01-31
PH12513A (en) 1979-04-20
IL52248A (en) 1980-09-16
AR214636A1 (es) 1979-07-13
GB1583062A (en) 1981-01-21
BG30773A3 (en) 1981-08-14
AT356049B (de) 1980-04-10
IE44992L (en) 1977-12-09
ATA402377A (de) 1979-09-15
DK144971B (da) 1982-07-19
DK247077A (da) 1977-12-10
PT66627A (en) 1977-07-01
GR66428B (enExample) 1981-03-23
DK144971C (da) 1982-12-13
US4064009A (en) 1977-12-20
HU174139B (hu) 1979-11-28
CH640000A5 (de) 1983-12-15
FR2354326B1 (enExample) 1980-02-08
DD131020A5 (de) 1978-05-24
US4104282A (en) 1978-08-01

Similar Documents

Publication Publication Date Title
US3983140A (en) Physiologically active substances
DE3006216C2 (de) Monacolin K, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
US4049495A (en) Physiologically active substances and fermentative process for producing the same
EP0049858B1 (de) Verfahren zur Herstellung von N-substituierten Derivaten des 1-Desoxynojirimycins
DE3122499A1 (de) Neue derivate von ml-236b, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittelzubereitungen
DE3006215A1 (de) Verfahren zur herstellung von monacolin k
DE68910213T2 (de) Antibiotikum R106.
EP0366060B1 (de) Glykosidase-Inhibitor Salbostatin, Verfahren zu seiner Herstellung und seine Verwendung
DE2343587A1 (de) Verfahren zur herstellung von 2-ketol-gulonsaeure
DE2631048B2 (de) Verfahren zur Herstellung von D-Phenylglycin
DE2725713A1 (de) Neue derivate von 3-alkyl-1,9-dihydroxy- und -1-hydroxy-9-keto-dibenzo eckige klammer auf b,d eckige klammer zu pyranen
DE68903907T2 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE2708149C2 (de) Verfahren zur Herstellung von Ubichinon-10
DE69908569T2 (de) Verfahren zur herstellung von fexofenadin
US3597325A (en) Production of 3-(2-nitro-3-chlorophenyl)-4-chloro-pyrrole
US4166764A (en) Production of monorden
DE2445581A1 (de) Verfahren zur herstellung von d-gluconsaeure-delta-lactam
EP0583687A2 (de) Verfahren zur Herstellung substituierter Methoxyphenole und dafür geeignete Mikroorganismen
DE3247175A1 (de) Dihydro- und tetrahydromonacolin l, ihre metallsalze und alkylester sowie verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3041130C2 (enExample)
DE3243924A1 (de) Mycotrienin-aehnliche verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2316429A1 (de) Verfahren zur herstellung eines neuen metaboliten
DE3881566T2 (de) Antitumor-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
KR810000419B1 (ko) 3-(산화된 알킬)-디벤조[b.d]피란유도체의 제조방법
DE2524574C3 (de) 5-(p-Hydroxybenzyl)-picolinsäure, Verfahren zu ihrer Herstellung und Isolierung sowie ihre Verwendung

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: SPOTT, G., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 800

8141 Disposal/no request for examination